Table of contents


On 8 August 2000, orphan designation (EU/3/00/001) was granted by the European Commission to Ares-Serono (Europe) Ltd., United Kingdom, for somatropin for AIDS wasting.

The sponsorship was transferred to Serono Europe Limited, United Kingdom, in May 2002. The name of the sponsor changed to Merck Serono Europe Limited in November 2009.

Please note that this product was withdrawn from the Union Register of orphan medicinal products in October 2020 on request of the Sponsor.

Key facts

Active substance
Disease / condition
AIDS wasting
Date of first decision
EU designation number

Sponsor's contact details

Merck Serono Europe Limited
56 Marsh Wall
London E14 9TP
United Kingdom
Telephone: +44 20 79 87 10 00
Telefax: +44 20 75 36 33 88

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating